Digital Therapeutics For Atopic Dermatitis Global Market Report 2026
상품코드:1951715
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
아토피 피부염용 디지털 치료제 시장 규모는 최근 급격하게 확대하고 있습니다. 2025년 5억 7,000만 달러에서 2026년에는 7억 달러로, CAGR 21.5%로 성장할 것으로 예상됩니다. 지난 수년간의 성장세는 아토피 피부염 발병률 증가, 피부과 분야 디지털 헬스 툴 도입 확대, 원격의료에 대한 환자 수요 증가, 디지털 피부과 솔루션의 조기 임상 검증, 모바일 헬스 플랫폼의 확대 등이 주요 요인으로 꼽힙니다.
아토피 피부염용 디지털 치료제 시장 규모는 향후 몇 년간 급격한 성장이 전망됩니다. 2030년에는 15억 달러에 달하고, CAGR은 21.2%가 될 전망입니다. 예측 기간 동안의 성장 요인으로는 피부과 영역에서의 처방 디지털 치료제 사용 확대, 커넥티드 모니터링 기기와의 연계 강화, 예방 및 장기 치료 프로그램 확대, 디지털 피부 건강 플랫폼에 대한 투자 증가, 의료 서비스 제공자의 수용성 향상 등을 꼽을 수 있습니다. 예측 기간의 주요 동향으로는 앱 기반 질환 관리 도구 도입 확대, 웨어러블 피부 모니터링 기기 사용 증가, 맞춤형 치료 지원 플랫폼 확대, 원격 피부과 솔루션 통합 촉진, 치료 순응도 및 환자 교육에 대한 집중 강화 등을 들 수 있습니다.
스마트폰의 보급 확대는 향후 몇 년 동안 아토피 피부염 디지털 치료제 시장의 성장을 견인할 것으로 예상됩니다. 스마트폰은 통신 기능, 인터넷 접속, 컴퓨팅 기능을 하나의 기기에 통합한 휴대용 단말기입니다. 인터넷 보급률이 증가함에 따라 더 많은 사람들이 디바이스에서 직접 온라인 서비스, 소셜 미디어, 디지털 엔터테인먼트에 편리하게 접속할 수 있게 되면서 그 인기가 높아지고 있습니다. 높은 스마트폰 보급률은 환자들이 모바일 애플리케이션과 디지털 플랫폼에 쉽고 지속적으로 접근할 수 있도록함으로써 아토피 피부염 디지털 치료를 돕습니다. 이를 통해 실시간 증상 추적, 치료 알림, 개인별 맞춤 가이드를 통해 치료 순응도 및 전반적인 질병 관리를 개선할 수 있습니다. 예를 들어, 2023년 2월 영국의 온라인 전화 비교 및 전환 서비스 제공업체인 Uswitch Limited가 발표한 보고서에 따르면, 2022년 활성 모바일 연결 수는 7,180만 건, 2025년까지 영국 거주자 6,830만 명 중 95%가 스마트폰을 소유할 것으로 예상됩니다. 스마트폰을 소유할 것으로 예상됩니다. 따라서 스마트폰의 보급 확대는 아토피 피부염용 디지털 치료제 시장의 성장을 촉진할 것으로 예상됩니다.
아토피 피부염 디지털 치료제 시장의 주요 기업들은 자금 지원과 더불어 멘토링, 업계 네트워크, 전략적 가이드를 제공하는 시드 펀드 설립에 중점을 두고 있습니다. 시드 펀드란 스타트업이 초기 단계에서 콘셉트, 제품, 사업 운영을 발전시키기 위한 투자 재원입니다. 예를 들어, 2023년 5월 독일에 본사를 둔 AI 기반 피부과 영상 솔루션 제공 업체인 Nia Health는 시드 펀딩 라운드에서 410만 달러(350만 유로)를 확보했다고 발표했습니다. 이번 투자를 통해 베를린 샤리테 대학병원에서 개발한 아토피 피부염 디지털 치료 앱 개발을 더욱 가속화할 예정입니다. 이 자금은 독일어권에서의 존재감 강화, 향후 2년간 EU 국가로의 확장, 미국 시장 진출을 위한 준비를 통한 성장을 지원합니다. 또한 기계 시각, 자연어 처리, 원격 피부과 진료 기능 등 앱의 AI 기반 기능 고도화에도 활용됩니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 공급망 분석
제4장 세계 시장 동향과 전략
제5장 최종 이용 산업 시장 분석
제6장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세의 영향, 관세 전쟁과 무역 보호주의가 공급망에 미치는 영향, 코로나가 시장에 미치는 영향을 포함한 거시경제 시나리오
제7장 세계의 전략 분석 프레임워크, 현재 시장 규모, 시장 비교 및 성장률 분석
제8장 시장에서 세계의 총 잠재 시장 규모(TAM)
제9장 시장 세분화
제10장 지역별, 국가별 분석
제11장 아시아태평양 시장
제12장 중국 시장
제13장 인도 시장
제14장 일본 시장
제15장 호주 시장
제16장 인도네시아 시장
제17장 한국 시장
제18장 대만 시장
제19장 동남아시아 시장
제20장 서유럽 시장
제21장 영국 시장
제22장 독일 시장
제23장 프랑스 시장
제24장 이탈리아 시장
제25장 스페인 시장
제26장 동유럽 시장
제27장 러시아 시장
제28장 북미 시장
제29장 미국 시장
제30장 캐나다 시장
제31장 남미 시장
제32장 브라질 시장
제33장 중동 시장
제34장 아프리카 시장
제35장 시장 규제 상황과 투자 환경
제36장 경쟁 구도와 기업 개요
제37장 기타 주요 기업과 혁신적 기업
제38장 세계의 시장 경쟁 벤치마킹과 대시보드
제39장 주요 인수합병
제40장 시장 잠재력이 높은 국가, 부문, 전략
제41장 부록
KSM
영문 목차
영문목차
Digital therapeutics for atopic dermatitis are technology-based interventions that utilize clinically validated software to aid in managing the condition. They aim to modify patient behavior and offer guidance grounded in research-backed approaches to enhance treatment adherence, symptom management, and overall skin health.
The main product types of digital therapeutics for atopic dermatitis include software applications, devices, and platforms. Software applications are digital programs created to perform specific functions and provide therapeutic interventions via computers or mobile devices. They are applied for disease management, preventive care, and treatment support and are used by various end-users, including patients, healthcare providers, payers, and others. Distribution channels include both online and offline methods.
Tariffs are impacting the digital therapeutics for atopic dermatitis market by increasing costs of imported wearable sensors, diagnostic devices, connectivity modules, and supporting electronics used in monitoring and feedback systems. Healthcare providers and digital health developers in North America and Europe are most affected due to reliance on imported components, while Asia-Pacific faces cost pressure in device manufacturing. These tariffs are raising deployment costs and slowing large-scale rollouts. However, they are also promoting local device assembly, software-led therapeutic development, and broader adoption of cloud-based digital care solutions.
The digital therapeutics for atopic dermatitis market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics for atopic dermatitis market statistics, including digital therapeutics for atopic dermatitis industry global market size, regional shares, competitors with a digital therapeutics for atopic dermatitis market share, detailed digital therapeutics for atopic dermatitis market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics for atopic dermatitis industry. This digital therapeutics for atopic dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The digital therapeutics for atopic dermatitis market size has grown exponentially in recent years. It will grow from $0.57 billion in 2025 to $0.7 billion in 2026 at a compound annual growth rate (CAGR) of 21.5%. The growth in the historic period can be attributed to growing prevalence of atopic dermatitis, rising adoption of digital health tools in dermatology, increased patient demand for remote care, early clinical validation of digital dermatology solutions, expansion of mobile health platforms.
The digital therapeutics for atopic dermatitis market size is expected to see exponential growth in the next few years. It will grow to $1.5 billion in 2030 at a compound annual growth rate (CAGR) of 21.2%. The growth in the forecast period can be attributed to increasing use of prescription digital therapeutics in dermatology, rising integration with connected monitoring devices, expansion of preventive and long-term care programs, growing investments in digital skin health platforms, increasing acceptance by healthcare providers. Major trends in the forecast period include increasing adoption of app-based disease management tools, growing use of wearable skin monitoring devices, expansion of personalized treatment support platforms, rising integration of teledermatology solutions, enhanced focus on treatment adherence and patient education.
The rising adoption of smartphones is anticipated to drive the growth of the digital therapeutics for atopic dermatitis market in the coming years. Smartphones are portable devices that combine communication, internet access, and computing capabilities into a single device. Their popularity is growing due to increasing internet penetration, which enables more people to conveniently access online services, social media, and digital entertainment directly from their devices. High smartphone penetration supports digital therapeutics for atopic dermatitis by offering patients easy and continuous access to mobile applications and digital platforms, facilitating real-time symptom tracking, treatment reminders, and personalized guidance, which enhances adherence and overall disease management. For example, in February 2023, a report by Uswitch Limited, a UK-based online and telephone comparison and switching service provider, stated that there were 71.8 million active mobile connections in 2022, and by 2025, it is projected that 95% of the 68.3 million people living in the UK will own smartphones. Consequently, the increasing adoption of smartphones is expected to drive the growth of the digital therapeutics for atopic dermatitis market.
Major companies in the digital therapeutics for atopic dermatitis market are emphasizing the establishment of seed funds to provide mentorship, industry connections, and strategic guidance alongside financial support. Seed funds are investment resources offered to startups in their early stages to help develop their concepts, products, and business operations. For example, in May 2023, Nia Health, a Germany-based provider of AI-powered dermatological imaging solutions, announced that it had secured $4.1 million (€3.5 million) in a seed funding round. The investment will enable the company to further develop its digital therapeutics app for atopic dermatitis, initially created at Charite Universitatsmedizin Berlin. The funding will support growth by enhancing its presence in German-speaking regions, expanding into other EU countries over the next two years, and preparing for the US market. It will also be used to advance the app's AI-driven features, including machine vision, natural language processing, and teledermatology capabilities.
In December 2023, Aptar Digital Health, a US-based provider of digital health solutions, formed a partnership with Legit.Health to enhance the patient experience in immuno-dermatology. As a result of the collaboration, Aptar's Digital Health platform will integrate Legit.Health's advanced technology, which can aid in diagnosing approximately 300 conditions, including atopic dermatitis, psoriasis, and skin cancer. This integration aims to improve patient care and empower patients by helping healthcare professionals detect skin conditions earlier and enabling patients to begin treatment sooner, thereby improving their overall quality of life. Legit.Health is a Spain-based medical software company.
Major companies operating in the digital therapeutics for atopic dermatitis market are Pfizer Inc., AbbVie Inc., Sanofi, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd., OMRON Corporation, Galderma S.A., Incyte Corporation, Chugai Pharmaceutical Co. Ltd., Teladoc Health Inc., LEO Pharma A/S, Almirall S.A., Biofourmis Inc., Click Therapeutics Inc., DarioHealth Corp., Sidekick Health GmbH, Digital Diagnostics Inc., Liva Healthcare A/S, 3Derm Systems
North America was the largest region in the digital therapeutics for atopic dermatitis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital therapeutics for atopic dermatitis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the digital therapeutics for atopic dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The digital therapeutics for atopic dermatitis market consists of revenues earned by entities by providing services such as personalized treatment plans, symptom tracking, and teleconsultation support. The market value includes the value of related goods sold by the service provider or included within the service offering. the digital therapeutics for atopic dermatitis market also includes sales of smart patches, wearable sensors, skin imaging devices, and portable dermatoscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Digital Therapeutics For Atopic Dermatitis Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses digital therapeutics for atopic dermatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for digital therapeutics for atopic dermatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics for atopic dermatitis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Scope
Markets Covered:1) By Product Type: Software Applications; Devices; Platforms
2) By Application: Disease Management; Preventive Care; Treatment Support
3) By End-User: Patients; Healthcare Providers; Payers; Other End-Users
4) By Distribution Channel: Online; Offline
Subsegments:
1) By Software Applications: Mobile Applications; Web Applications; Desktop Applications; Cloud-Based Applications
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.
4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
4.1.3 Biotechnology, Genomics & Precision Medicine
4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
4.1.5 Immersive Technologies (Ar/Vr/Xr) & Digital Experiences
4.2. Major Trends
4.2.1 Increasing Adoption Of App-Based Disease Management Tools
4.2.2 Growing Use Of Wearable Skin Monitoring Devices
4.2.3 Expansion Of Personalized Treatment Support Platforms
4.2.4 Rising Integration Of Teledermatology Solutions
4.2.5 Enhanced Focus On Treatment Adherence And Patient Education
5. Digital Therapeutics For Atopic Dermatitis Market Analysis Of End Use Industries
5.1 Patients
5.2 Healthcare Providers
5.3 Dermatology Clinics
5.4 Digital Health Companies
5.5 Payers
6. Digital Therapeutics For Atopic Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market
7. Global Digital Therapeutics For Atopic Dermatitis Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis
7.1. Global Digital Therapeutics For Atopic Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Digital Therapeutics For Atopic Dermatitis Market Size, Comparisons And Growth Rate Analysis
7.3. Global Digital Therapeutics For Atopic Dermatitis Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Digital Therapeutics For Atopic Dermatitis Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)
8. Global Digital Therapeutics For Atopic Dermatitis Total Addressable Market (TAM) Analysis for the Market
8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis
9. Digital Therapeutics For Atopic Dermatitis Market Segmentation
9.1. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Software Applications, Devices, Platforms
9.2. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Disease Management, Preventive Care, Treatment Support
9.3. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Patients, Healthcare Providers, Payers, Other End-Users
9.4. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Online, Offline
9.5. Global Digital Therapeutics For Atopic Dermatitis Market, Sub-Segmentation Of Software Applications, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Mobile Applications, Web Applications, Desktop Applications, Cloud-Based Applications
9.6. Global Digital Therapeutics For Atopic Dermatitis Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
9.7. Global Digital Therapeutics For Atopic Dermatitis Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Patient Management Platforms, Clinician Support Platforms, Data Analytics Platforms, Telehealth Platforms
10. Digital Therapeutics For Atopic Dermatitis Market Regional And Country Analysis
10.1. Global Digital Therapeutics For Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Digital Therapeutics For Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
11. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market
11.1. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
12. China Digital Therapeutics For Atopic Dermatitis Market
12.1. China Digital Therapeutics For Atopic Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
13. India Digital Therapeutics For Atopic Dermatitis Market
13.1. India Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
14. Japan Digital Therapeutics For Atopic Dermatitis Market
14.1. Japan Digital Therapeutics For Atopic Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
15. Australia Digital Therapeutics For Atopic Dermatitis Market
15.1. Australia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
16. Indonesia Digital Therapeutics For Atopic Dermatitis Market
16.1. Indonesia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
17. South Korea Digital Therapeutics For Atopic Dermatitis Market
17.1. South Korea Digital Therapeutics For Atopic Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
18. Taiwan Digital Therapeutics For Atopic Dermatitis Market
18.1. Taiwan Digital Therapeutics For Atopic Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
19. South East Asia Digital Therapeutics For Atopic Dermatitis Market
19.1. South East Asia Digital Therapeutics For Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
20. Western Europe Digital Therapeutics For Atopic Dermatitis Market
20.1. Western Europe Digital Therapeutics For Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
21. UK Digital Therapeutics For Atopic Dermatitis Market
21.1. UK Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
22. Germany Digital Therapeutics For Atopic Dermatitis Market
22.1. Germany Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
23. France Digital Therapeutics For Atopic Dermatitis Market
23.1. France Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
24. Italy Digital Therapeutics For Atopic Dermatitis Market
24.1. Italy Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
25. Spain Digital Therapeutics For Atopic Dermatitis Market
25.1. Spain Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
26. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market
26.1. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
27. Russia Digital Therapeutics For Atopic Dermatitis Market
27.1. Russia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
28. North America Digital Therapeutics For Atopic Dermatitis Market
28.1. North America Digital Therapeutics For Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
29. USA Digital Therapeutics For Atopic Dermatitis Market
29.1. USA Digital Therapeutics For Atopic Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
30. Canada Digital Therapeutics For Atopic Dermatitis Market
30.1. Canada Digital Therapeutics For Atopic Dermatitis Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
31. South America Digital Therapeutics For Atopic Dermatitis Market
31.1. South America Digital Therapeutics For Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
32. Brazil Digital Therapeutics For Atopic Dermatitis Market
32.1. Brazil Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
33. Middle East Digital Therapeutics For Atopic Dermatitis Market
33.1. Middle East Digital Therapeutics For Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
34. Africa Digital Therapeutics For Atopic Dermatitis Market
34.1. Africa Digital Therapeutics For Atopic Dermatitis Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Segmentation By Application, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
35. Digital Therapeutics For Atopic Dermatitis Market Regulatory and Investment Landscape
36. Digital Therapeutics For Atopic Dermatitis Market Competitive Landscape And Company Profiles
36.1. Digital Therapeutics For Atopic Dermatitis Market Competitive Landscape And Market Share 2024
36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Digital Therapeutics For Atopic Dermatitis Market - Company Scoring Matrix
36.2.1. Market Revenues
36.2.2. Product Innovation Score
36.2.3. Brand Recognition
36.3. Digital Therapeutics For Atopic Dermatitis Market Company Profiles
36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
36.3.3. Sanofi Overview, Products and Services, Strategy and Financial Analysis
36.3.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
36.3.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
37. Digital Therapeutics For Atopic Dermatitis Market Other Major And Innovative Companies
Otsuka Pharmaceutical Co. Ltd., OMRON Corporation, Galderma S.A., Incyte Corporation, Chugai Pharmaceutical Co. Ltd., Teladoc Health Inc., LEO Pharma A/S, Almirall S.A., Biofourmis Inc., Click Therapeutics Inc., DarioHealth Corp., Sidekick Health GmbH, Digital Diagnostics Inc., Liva Healthcare A/S, 3Derm Systems
38. Global Digital Therapeutics For Atopic Dermatitis Market Competitive Benchmarking And Dashboard
39. Key Mergers And Acquisitions In The Digital Therapeutics For Atopic Dermatitis Market
40. Digital Therapeutics For Atopic Dermatitis Market High Potential Countries, Segments and Strategies
40.1 Digital Therapeutics For Atopic Dermatitis Market In 2030 - Countries Offering Most New Opportunities
40.2 Digital Therapeutics For Atopic Dermatitis Market In 2030 - Segments Offering Most New Opportunities
40.3 Digital Therapeutics For Atopic Dermatitis Market In 2030 - Growth Strategies
